Oligomerization-induced modulation of TPR-MET tyrosine kinase activity.

作者: John L. Hays , Stanley J. Watowich

DOI: 10.1074/JBC.M210648200

关键词:

摘要: Abstract Phosphorylation, although necessary, may not be sufficient to fully activate many receptor tyrosine kinases (RTKs). Oligomerization-induced conformational changes necessary modulate the kinetic properties of RTKs and render them functional. To investigate this regulatory mechanism, recombinant TPR-MET, a functionally active oncoprotein derivative RTK c-MET, has been expressed purified for quantitative enzymatic analysis. This naturally occurring contains cytoplasmic domain c-MET fused coiled coil motif from nuclear pore complex (TPR). cytoMET, monomeric analog also comparative ATP peptide substrates have kinetically characterized both TPR-MET cytoMET. Significantly, phosphorylated smaller Km values (Km,ATP) (Km,peptide) larger kcat relative provides first direct evidence that oligomerization simply activation loop phosphorylation modulates activity. The dissociation constants (Kd,ATP) two enzymes displayed significant differences. In contrast, KI competitive inhibitor staurosporin are similar enzymes. These results suggest much oligomerization-induced occur with respect substrate binding or catalytic efficiency. possibility within implications structure-based design inhibitors development detailed mechanistic model activation.

参考文章(27)
Flavio Meggio, Arianna Donella Deana, Maria Ruzzene, Anna M. Brunati, Luca Cesaro, Barbara Guerra, Thomas Meyer, Helmut Mett, Doriano Fabbro, Pascal Furet, Grazyna Dobrowolska, Lorenzo A. Pinna, Different susceptibility of protein kinases to staurosporine inhibition Kinetic studies and molecular bases for the resistance of protein kinase CK2 FEBS Journal. ,vol. 234, pp. 317- 322 ,(1995) , 10.1111/J.1432-1033.1995.317_C.X
B.I. Posner, R. Faure, J.W. Burgess, A.P. Bevan, D. Lachance, G. Zhang-Sun, I.G. Fantus, J.B. Ng, D.A. Hall, B.S. Lum, Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. Journal of Biological Chemistry. ,vol. 269, pp. 4596- 4604 ,(1994) , 10.1016/S0021-9258(17)41818-7
Kunrong Cheng, John G. Koland, Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-tyrosine Kinase TRINITROPHENYL-ATP AS A SPECTROSCOPIC PROBE Journal of Biological Chemistry. ,vol. 271, pp. 311- 318 ,(1996) , 10.1074/JBC.271.1.311
Alexander Levitzki, Protein tyrosine kinase inhibitors as novel therapeutic agents. Pharmacology & Therapeutics. ,vol. 82, pp. 231- 239 ,(1999) , 10.1016/S0163-7258(98)00066-7
Peter Traxler, Pascal Furet, Strategies Toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors Pharmacology & Therapeutics. ,vol. 82, pp. 195- 206 ,(1999) , 10.1016/S0163-7258(98)00044-8
Camran V. Parast, Barbara Mroczkowski, Chris Pinko, Shawn Misialek, Godrej Khambatta, Krzysztof Appelt, Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis. Biochemistry. ,vol. 37, pp. 16788- 16801 ,(1998) , 10.1021/BI981291F